Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicasio Mancini

Showing results (71-80 of 166) with videos related to

Pageof 17
Sort By:
The Journal of Infectious Diseases|June 20, 2020
Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus InfectionNicola Clementi, Roberto Ferrarese, Elena Criscuolo, et al.
Viruses|May 11, 2016
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with NatalizumabRoberta Antonia Diotti, Ruggero Capra, Lucia Moiola, et al.
Gut|February 10, 2015
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoproteinGiuseppe A Sautto, Karin Wisskirchen, Nicola Clementi, et al.
Antibiotics (Basel, Switzerland)|November 27, 2021
In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against <i>Acinetobacter baumannii</i> Strains Recovered from Clinical SamplesDavide Carcione, Claudia Siracusa, Adela Sulejmani, et al.
Clinical Chemistry and Laboratory Medicine|May 28, 2020
Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidenceMary Kathryn Bohn, Giuseppe Lippi, Andrea Horvath, et al.
Autoimmunity Reviews|June 19, 2008
Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemiaMario Perotti, Nadia Ghidoli, Raffaele Altara, et al.
Plos One|December 17, 2009
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypesNicasio Mancini, Roberta A Diotti, Mario Perotti, et al.
Vaccines|November 27, 2021
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 VaccineDavide Ferrari, Nicola Clementi, Elena Criscuolo, et al.
Clinical Chemistry and Laboratory Medicine|June 19, 2020
Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global surveyTze Ping Loh, Andrea Rita Horvath, Cheng-Bin Wang, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 2, 2023
Genetic characterization of Klebsiella pneumoniae carbapenemase -producing Klebsiella pneumoniae isolates with different susceptibility to ceftazidime/avibactam in patients with blood-stream infectionsFlavia Badalucco Ciotta, Francesca Saluzzo, Alessandra Pescò, et al.
Pageof 17

Showing results (71-80 of 166) with videos related to

Sort By:
Pageof 17
The Journal of Infectious Diseases|June 20, 2020
Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus InfectionNicola Clementi, Roberto Ferrarese, Elena Criscuolo, et al.
Viruses|May 11, 2016
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with NatalizumabRoberta Antonia Diotti, Ruggero Capra, Lucia Moiola, et al.
Gut|February 10, 2015
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoproteinGiuseppe A Sautto, Karin Wisskirchen, Nicola Clementi, et al.
Antibiotics (Basel, Switzerland)|November 27, 2021
In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against <i>Acinetobacter baumannii</i> Strains Recovered from Clinical SamplesDavide Carcione, Claudia Siracusa, Adela Sulejmani, et al.
Clinical Chemistry and Laboratory Medicine|May 28, 2020
Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidenceMary Kathryn Bohn, Giuseppe Lippi, Andrea Horvath, et al.
Autoimmunity Reviews|June 19, 2008
Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemiaMario Perotti, Nadia Ghidoli, Raffaele Altara, et al.
Plos One|December 17, 2009
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypesNicasio Mancini, Roberta A Diotti, Mario Perotti, et al.
Vaccines|November 27, 2021
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 VaccineDavide Ferrari, Nicola Clementi, Elena Criscuolo, et al.
Clinical Chemistry and Laboratory Medicine|June 19, 2020
Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global surveyTze Ping Loh, Andrea Rita Horvath, Cheng-Bin Wang, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 2, 2023
Genetic characterization of Klebsiella pneumoniae carbapenemase -producing Klebsiella pneumoniae isolates with different susceptibility to ceftazidime/avibactam in patients with blood-stream infectionsFlavia Badalucco Ciotta, Francesca Saluzzo, Alessandra Pescò, et al.
Pageof 17